Letter: proton pump inhibitor use and bone fracture risk-a mechanistic point of view
Aliment Pharmacol Ther
.
2021 Mar;53(5):671-672.
doi: 10.1111/apt.16231.
Author
Toshihiro Sugiyama
1
Affiliation
1
Department of Orthopaedic Surgery, Saitama Medical University, Saitama, Japan.
PMID:
33566413
DOI:
10.1111/apt.16231
No abstract available
Publication types
Letter
Comment
MeSH terms
Hip Fractures*
Humans
Liver Cirrhosis
Male
Proton Pump Inhibitors* / adverse effects
Substances
Proton Pump Inhibitors